Breakthrough in Cancer Genetics and Cytogenetics Helps in Treatment

Posted by Ashwini Chawla on December 4th, 2020

Cancer is a leading cause of death the world over. Through cancer genetics and cytogenetics it is possible to find new ways to tackle disease and use new methods of treatment.

The Use of Panels to Test

By nature, testing is essential to determine the best way to treat an ailment. You can make use of a comprehensive number of tests in cancer genetics and cytogenetics services including imaging tests, blood tests, MRI, and CT scans among others. The cancer genetics and cytogenetics program helps clinicians take the appropriate action for cancer patients. They do this through genetic diagnosis. Testing panels for solid tumours and combining the treatment choices through many test methods like FISH, sequencing, and immunohistochemistry helps the physician arrive at a holistic solution.

Testing for Diseases

To detect and deal with blood cancer, the genetic testing companies in India use FISH, conventional karyotyping, and sequencing. These panels help detect ailments such as Acute Myeloid leukaemia, myelodysplastic syndromes, and chronic lymphocytic leukaemia. Genetics plays a crucial role in prognostication and disease classification of sarcomas. These rich testing menus cover synovial sarcoma, Ewing’s sarcoma, Myxoid liposarcoma, and liposarcoma among others.

The Usefulness of NGS

The team of specialists at the genetic testing companies in India carries out molecular and genomic studies using an ultra-high-throughput sequencing technology known as Next Generation Sequencing (NGS). The team uses NGS to study and analyze complex genetic conditions because they get better access through NGS. It sequences whole genomes fast and sequences targetted regions to a deep level.

Through this, it is possible to detect inborn defects of the metabolism and point mutations in autosomal recessive conditions. You can identify neuromuscular disorders such as hereditary neuropathy and Charcot - Marie Tooth disease.